Attardi B, Happe H K
Endocrinology. 1986 Jul;119(1):274-83. doi: 10.1210/endo-119-1-274.
The present study examined the question of whether modulation of estradiol-induced LH surges by progesterone or antiestrogens in the immature rat might be related to changes in the concentration of pituitary GnRH receptors (GnRH-R). Rats (28 days old) that received estradiol implants at 0900 h had LH surges approximately 32 h later. Administration of progesterone or nafoxidine (U-11,100 A; 1-(2-[P-(3,4-dihydro-6-methoxy-2-phenyl-1-naphthyl)phenoxy]pyrrolidine hydrochloride) concomitantly with estradiol led to blockade of these LH surges (progesterone or nafoxidine inhibition), while progesterone treatment 24 h after estradiol brought about premature and enhanced LH release (progesterone facilitation). GnRH-R-binding capacity was determined by saturation analysis in homogenates of single pituitaries from immature rats treated with estradiol and progesterone or nafoxidine and controls treated only with estradiol using [125I]iodo-(D-Ala6,Des-Gly10)GnRh ethylamide. The affinity of GnRH-R for this analog ranged from 8.2-15.1 X 10(9) M-1 and was not affected by in vivo steroid or antiestrogen treatment. The number of GnRH-R in gonadotrophs from untreated 28-day-old rats (57.2 +/- 2.6 fmol/pituitary or 177 +/- 11 fmol/mg protein) was comparable to values previously reported for 30 day-old females. GnRH-R levels were first measured 1, 8, 24, 32, and 48 h after estradiol treatment. The pituitary content of GnRH-R paralleled changes in total pituitary protein (nadir at 24 h, rebound at 32 h, continued increase at 48 h), while their concentration (femtomoles per mg protein) was highest at 8 h. Next, GnRH-R levels were examined at 1200 h and at hourly intervals (1400-1800 h) on the afternoon of the LH surge. While GnRH-R concentrations were significantly lower at 1400 and 1700 h than at 1200 or 1800 h in animals treated with estradiol in the progesterone facilitation model, they did not change over time in the other two paradigms. There was no significant difference in pituitary content or concentration of GnRH-R at any time between immature rats treated with estradiol and progesterone or nafoxidine and their respective estradiol-treated controls. These results suggest that changes in GnRH-R levels in pituitary gonadotrophs do not play a major role in enhancement of LH surges by progesterone or in their suppression by progesterone or nafoxidine in the immature rat; therefore, these compounds may affect the pituitary at a site distal to the GnRH receptor.
本研究探讨了在未成熟大鼠中,孕酮或抗雌激素对雌二醇诱导的促黄体生成素(LH)峰的调节作用是否可能与垂体促性腺激素释放激素受体(GnRH-R)浓度的变化有关。于上午9点植入雌二醇的28日龄大鼠,约32小时后出现LH峰。与雌二醇同时给予孕酮或萘福昔定(U-11,100 A;1-(2-[P-(3,4-二氢-6-甲氧基-2-苯基-1-萘基)苯氧基]吡咯烷盐酸盐)可导致这些LH峰被阻断(孕酮或萘福昔定抑制),而在雌二醇给药24小时后给予孕酮则会使LH提前释放且释放量增加(孕酮促进)。使用[125I]碘代-(D-Ala6,Des-Gly10)GnRh乙酰胺,通过饱和分析测定来自接受雌二醇和孕酮或萘福昔定处理的未成熟大鼠单个垂体匀浆以及仅接受雌二醇处理的对照大鼠垂体匀浆中的GnRH-R结合能力。GnRH-R对该类似物的亲和力范围为8.2 - 15.1×10(9) M-1,且不受体内类固醇或抗雌激素处理的影响。未处理的28日龄大鼠促性腺细胞中的GnRH-R数量(57.2±2.6 fmol/垂体或177±11 fmol/mg蛋白质)与先前报道的30日龄雌性大鼠的值相当。在雌二醇处理后1、8、24、32和48小时首次测量GnRH-R水平。垂体中GnRH-R的含量与垂体总蛋白的变化平行(24小时时最低,32小时时反弹,48小时时持续增加),而其浓度(每毫克蛋白质的飞摩尔数)在8小时时最高。接下来,在LH峰当天下午12点及每小时(14点至18点)检测GnRH-R水平。在孕酮促进模型中接受雌二醇处理的动物中,14点和17点时GnRH-R浓度显著低于12点或18点时,但在其他两种模式下其浓度并未随时间变化。接受雌二醇和孕酮或萘福昔定处理的未成熟大鼠与其各自仅接受雌二醇处理的对照大鼠在任何时候垂体中GnRH-R的含量或浓度均无显著差异。这些结果表明,垂体促性腺细胞中GnRH-R水平的变化在未成熟大鼠中,对孕酮增强LH峰或孕酮或萘福昔定抑制LH峰的过程中不起主要作用;因此,这些化合物可能在GnRH受体远端的位点影响垂体。